BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains neutral on Torrent Pharma
Complementary acquisition but growth issues stay. Deal with Elder is earnings per share dilutive for the first two years. Target Rs 407.5.